Literature DB >> 7730638

Biologic activities of the beta-chemokine TCA3 on neutrophils and macrophages.

S Devi1, J Laning, Y Luo, M E Dorf.   

Abstract

Previous in vivo and in vitro studies demonstrated that the murine beta-chemokine TCA3 is a chemoattractant for monocytes/macrophages and neutrophils. The ability of TCA3 to activate these cell populations is now evaluated. Treatment with 10 to 20 nM rTCA3 induced a respiratory burst with the production of superoxide and hydrogen peroxide in both casein-elicited and unstimulated neutrophil and macrophage populations. In addition, TCA3 treatment induced the production of reactive nitrogen intermediates, whereas stimulation with higher concentrations (100 nM) of TCA3 induced the exocytosis of lysozyme and elastase in the presence of cytochalasin B (7 micrograms/ml). Subnanomolar concentrations (100 pM) of TCA3 also caused integrin-mediated increases of adhesiveness to fibrinogen by neutrophils and macrophages. Increased adhesiveness is the most sensitive assay for TCA3 bioactivity. TCA3 treatment appears to involve signaling through a G-protein-linked receptor as Pertussis toxin abolished the TCA3-mediated increase of adhesiveness and the production of reactive nitrogen intermediates. The dose dependence of the TCA3-mediated activities indicate a coordinated inflammatory response mediated by varying concentrations of TCA3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730638

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction.

Authors:  K L Buchanan; J W Murphy
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Murine astrocytes express a functional chemokine receptor.

Authors:  S Tanabe; M Heesen; M A Berman; M B Fischer; I Yoshizawa; Y Luo; M E Dorf
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

3.  HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine.

Authors:  T Tsuji; J Fukushima; K Hamajima; N Ishii; I Aoki; H Bukawa; Y Ishigatsubo; K Tani; T Okubo; M E Dorf; K Okuda
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  Gene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of the CNS.

Authors:  Derek D C Ireland; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

Review 5.  Granulocytes as models for human protein marker identification following nicotine exposure.

Authors:  Matthew J Mulcahy; Henry A Lester
Journal:  J Neurochem       Date:  2017-08       Impact factor: 5.372

6.  Rat macrophage inflammatory protein-1alpha, a CC chemokine, acts as a neutrophil chemoattractant in vitro and in vivo.

Authors:  K Takano; M Al-Mokdad; F Shibata; H Tsuchiya; H Nakagawa
Journal:  Inflammation       Date:  1999-10       Impact factor: 4.092

7.  Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection.

Authors:  Sherilyn Smith; Denny Liggitt; Elizabeth Jeromsky; Xiaoxia Tan; Shawn J Skerrett; Christopher B Wilson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

8.  Biological activities of C3 beta c, a novel neutrophil chemoattractant derived from the beta-chain of rat complement C3.

Authors:  H Nakagawa; Y Sunada; Y Ando
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

9.  Isolation of Mouse Neutrophils.

Authors:  Muthulekha Swamydas; Yi Luo; Martin E Dorf; Michail S Lionakis
Journal:  Curr Protoc Immunol       Date:  2015-08-03

10.  Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1.

Authors:  J L Gao; T A Wynn; Y Chang; E J Lee; H E Broxmeyer; S Cooper; H L Tiffany; H Westphal; J Kwon-Chung; P M Murphy
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.